This study was designed to calculate the background lifetime risk of cancer mortality in Japan. The mortality and population 0-4, 5-9, …, 80-lifetime risk of cancer mortality ranges from 23.7% to 28.3% among 47 prefectures, and the arithmetic mean was calculated to be 25.4%. It is important to consider the incremental risk of cancer mortality posed by exposure to ionizing radiation (e.g., an additive lifetime risk of 0.5% at the effective dose of 100 mSv) in the context of the level of the background lifetime risk of cancer mortality of the exposed population.
I INTRODUCTION
Ionizing radiation is a proven human carcinogen. 1) For the purpose of protecting the gender-averaged population from the harmful stochastic effects of ionizing radiation (i.e., cancer and hereditary diseases), the International Commission on Radiological Protection (ICRP) recommends the effective dose of 1 Sv with a 5% increase in additive risk to the background lifetime risk of cancer mortality (i.e., nominal risk coef cient of 5% Sv -1 ). 2, 3) Cancer has been the leading cause of death since 1981 in Japan, and the background lifetime risks of cancer mortality for males and females were previously calculated to be 29.4% and 20.5% in 1999, respectively. 4) In other words, approximately a third of males and a fth of females will die of cancer. A recent analysis of cancer trends reveals a decrease in mortality from the mid-1990s. 5) In the information dissemination on radiation exposure and its health effects after the Fukushima nuclear accident, the gender-averaged background lifetime risk of cancer mortality was frequently set as 30%, considering only the ratio of the annual rate of cancer mortality to that of mortality due to all causes (e.g., 357,305/1,253,066 = 0.285, from vital statistics data in 2011 6) ). This approach is not in line with the derivation of the nominal risk coef cient of 5% Sv -1 recommended by ICRP, 3) which is the lifetime risk estimate based on the epidemiological data on atomic bomb survivors. 7) The United Nations Scienti c Committee on the Effects of Atomic Radiation (UNSCEAR) describes in the Fukushima accident report 8) that the background lifetime risk of cancer mortality in Japan is normally about 35%, but there is no reference to such a description in the report. The Basic Law for Anticancer was enforced in April 2007 to promote the national cancer control program in Japan, and an index of the age-adjusted cancer mortality rate under age 75 by prefectures has been calculated for each type of cancer by the National Cancer Center of Japan.
9) The use of the ageadjusted methodology can eliminate the effect of aging in the population, and the selection of ages under 75 years can lead to a precise evaluation of the prime of one's life stage. Although this index has been playing an important role in the cancer control program to evaluate the decreasing tendency (i.e., from 92.7 in 2005 to 81.9 in 2012 per 100,000 population), 9) it is not an estimate of the lifetime risk of cancer mortality.
Taken together, the previous calculations of background lifetime risks of cancer mortality only provide the arithmetic mean for the whole country, and more speci c data have not been shown, such as the background lifetime risk of cancer mortality in a subgroup population in the country and the gender-averaged lifetime risk of cancer mortality, which are important when we consider issues of radiological protection using the concept of the nominal risk coef cient.
To this end, we set out to calculate the lifetime risk of cancer mortality for the gender-averaged population in all 47 prefectures in Japan, which are the country's 47 rst-order subnational jurisdictions; thus, the necessary information of vital statistics and population are publicly available. The methodology of calculating the background lifetime risk of cancer mortality is given in the next section.
II MATERIALS AND METHODS
The background lifetime risk of cancer mortality is de ned as an estimation of the probability that a newborn child dies of cancer in his or her lifetime regardless of exposure to ionizing 10) which has been widely used in reports such as the U.S. Surveillance, Epidemiology, and End Results Program of the National Cancer Institute 11) and the American Cancer Society. 12) On the basis of such a mathematical derivation, the lifetime risk of cancer mortality in Japan was reported by KAMO et al. (i.e., 29.4% for males and 20.5% for females as of 1999) 4) and by the National Cancer Center of Japan. 9) In this respect, we followed the same mathematical procedures as follows.
To calculate the lifetime risk of cancer mortality, statistical data on the total mortality rate, cancer-speci c mortality rate, and population are necessary for 5-year age intervals to construct a life table. 10) The mortality data originated from the vital statistics in 2010; such statistics are collected yearly by the Ministry of Health, Labour and Welfare.
6) The subjects of the survey are the total numbers of live births, deaths, marriages, divorces, and fetal deaths noti ed in accordance with the Family Registration Law and Provisions Regarding the Noti cation of Stillbirths, and the objects are events occurring among Japanese people living in Japan within the survey year. On the other hand, the population data originated from the 19th population census in 2010, which has been conducted almost every ve years since 1920 by the Ministry of Internal Affairs and Communications.
13) The survey of the population in each prefecture has generally been conducted only as part of the population census of Japan; thus, choosing the year 2010 in this study made it possible to calculate the background lifetime risk of cancer mortality on the basis of the most up-to-date statistical information available. In this respect, the year 2015 will be the next opportunity to calculate the lifetime risk of cancer mortality on the basis of the latest information about the Japanese population.
The mortality and population data obtained from the national surveys are strati ed at 5-year age intervals of 0-4, 5-9, …, 80-84, with a nal open interval of 85+ for use in the life table. The mortality data strati ed at these intervals were then converted to probabilities using the exponential model given by equation (1) . The equations shown hereinafter in this paper are the same as those used in the calculation of the lifetime risk of cancer mortality by KAMO et al. 4) and by the National Cancer Center of Japan 9) for consistency. Estimates were derived for each 5-year age group for a hypothetical cohort of 1 million live births, as shown in equations (2) and (3), where i represents the initial age of the interval (i.e., i = 0, 5, …, 85), q i represents the initial population at the age interval with the initial age i, and i represents the total mortality rate (i.e., cancer mortality rate and noncancer mortality rate) at the age interval with the initial age i.
(1)
The cancer mortality (m i ) at the age interval with the initial age i is given by equation (4), where i represents the corresponding cancer mortality rate.
The cancer mortality in the nal open interval of 85+ (m 85+ ) is calculated using equation (5).
Finally, the lifetime risk of cancer mortality was calculated by dividing the cumulative cancer mortality at all age intervals by the hypothetical cohort of 1 million live births. Table 1 shows the results of the background lifetime risk of cancer mortality in Japan as of 2010. The cancer mortality gures for all prefectures are shown for each age interval, and the lifetime risk of cancer mortality was obtained by dividing the cumulative cancer mortality at all age intervals (0 to 85+) by the hypothetical cohort of 1 million live births. For example, in the case of Hokkaido Prefecture shown as number 1, the cumulative cancer mortality per 1 million persons was calculated to be 282,832, which is the summation of the cancer mortalities at age intervals of 0-4, 5-9, …, 80-84 and 85+, and then the lifetime risk of cancer mortality was calculated to be 28.3% (i.e., 282,832/1,000,000 = 0.283).
III RESULTS AND DISCUSSION
The cancer mortality in each age interval was obtained using the exponential approximation given by equation (1) . In general, the absolute value of the calculated cancer mortality in the younger age intervals is smaller than those in the older age intervals as shown in Table 1 , and therefore, uncertainties in the calculated cancer mortality due to statistical errors largely depend on these age-intervals. However, considering the result that the contribution of calculated cancer mortality in the younger age intervals to the cumulative cancer mortality at all age intervals (0 to 85+) is generally trivial, we universally apply the exponential model given by equation (1) to all age intervals. This approach is the same that of KAMO et al. 4) and the National Cancer Center of Japan. 9) By conducting similar calculations for all 47 prefectures, it was found that the lifetime risk of cancer mortality ranges from 23.7% to 28.3% among the 47 prefectures, and the arithmetic mean was calculated to be 25.4%. Furthermore, a graphical distribution of the background lifetime risk of cancer mortality was obtained and is shown on a map of Japan (Fig. 1) using the geographic information system (GIS) mapping software of MANDARA Ver. 9.37. 14) Dietary habits may be one of the most important determinants for radiation-induced cancer risks in human populations. 15) Regarding the effect of lifestyle on the health of the Japanese population, a comprehensive assessment shows that 45% of cancers in both genders were attributable to known risk factors, such as tobacco smoking, infection, alcohol drinking, and salt intake. 16) In the Basic Plans to Promote Anticancer Measures in Japan, 17) one of the overall objectives has been to decrease the age-adjusted cancer mortality rate under age 75 by implementing comprehensive anticancer measures including countermeasures against tobacco smoking, infection, alcohol drinking, and other lifestyle-related solutions such as periodical physical activity, maintenance of the appropriate weight, increase in the intake of vegetables and fruit, and decrease in the intake of salt, as well as the promotion of medical examination and cancer treatment. Although the de nition of the index of the age-adjusted cancer mortality rate under age 75 given by the National Cancer Center of Japan is different from that of the background lifetime risk of cancer mortality calculated in this paper, it can be considered that the variance of the lifetime risk of cancer mortality among the 47 prefectures (i.e., approximately 5% between the maximum and minimum risks) revealed in this study is mainly due to the different lifestyles of the Japanese population.
One of the challenging issues that have emerged from the present ndings on the background lifetime risk of cancer mortality is the understanding of the additive cancer risk from exposure to ionizing radiation. For the purpose of radiological protection, ICRP recommends the use of the approximated overall fatal risk coef cient, which assumes that low-dose (i.e., less than 0.2 Gy) and low-dose-rate (i.e., less than 0.1 Gy h -1 ) exposures to ionizing radiation at the effective dose of 100 mSv lead to a 0.5% increase in additive risk to the background lifetime risk of cancer mortality, 2, 3) while the gender-averaged risk for the whole population is calculated to be 5.74% Sv -1 .
3)
The United Nations Scienti c Committee on the Effects of Atomic Radiation (UNSCEAR), on the other hand, reported in its UNSCEAR 2006 Report 18) that the lifetime risk of exposure-induced death due to all solid cancers combined following an acute dose of 0.1 Sv is estimated to be about 3.6-7.7% Sv -1 averaged over both genders, and at 1 Sv the risk is about 4.3-7.2% Sv -1 . Note that these numerical values in the UNSCEAR 2006 Report 18) can vary for different populations and with different risk models. Given the approximated overall fatal risk coef cient recommended by ICRP 2, 3) and the risk coef cient reported by UNSCEAR, 18) it can be argued that, on the basis of the calculation in this study, the incremental lifetime risk of cancer mortality due to exposure to ionizing radiation at the effective dose of 100 mSv is only about onetenth of the variance of the prefectural distribution of the background cancer mortality risk in Japan (i.e., approximately 5%), or others might argue that any incremental risks from unnecessary exposure to ionizing radiation should be avoided by taking countermeasures. Note that this study does not show that there is no radiation-induced cancer risk below a certain radiation dose nor that the current situation regarding the background lifetime risk of cancer mortality in Japan is acceptable, and should not be interpreted in such ways. Rather, it is important to bear in mind that the incremental risk from exposure to ionizing radiation is to be added to the background lifetime risk of cancer mortality, which has variations within the population, and that the exposure to ionizing radiation is a risk factor for cancer mortality. In this respect, one of the most important principles in the protection of people from the stochastic effects of ionizing radiation is the optimization of radiological protection, which is to keep the likelihood of incurring exposures, the number of people exposed, and the magnitude of individual doses as low as reasonably achievable, taking societal and economic factors into account. The present nding on the background lifetime risk of cancer mortality has important implications for developing a balanced implementation of radiological protection taking into consideration the societal and economic factors in light of the optimization of radiological protection.
IV CONCLUSIONS
We calculated the background lifetime risk of cancer mortality in Japan using the latest vital statistics and population census in 2010. The gender-averaged lifetime risk of cancer mortality ranges from 23.7% to 28.3% among the 47 prefectures, and the arithmetic mean was calculated to be 25.4%. It is important for the purpose of radiological protection to consider the additive risk from exposure to ionizing radiation, recognizing the level of the background lifetime risk of cancer mortality of the exposed population. Finally, we hope that our ndings will be widely used in the information dissemination on radiation exposure and its health effects in Japan, and help to provide a basis for a commensurate response with the associated radiological risks and the optimization of radiological protection.
